Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
17.14
-0.50 (-2.83%)
Sep 10, 2026, 11:59 AM HKT

HKG:1877 Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, HKG:1877 stock has a consensus rating of "Buy" and an average price target of $31.63. The average 1-year stock price forecast is 84.54% higher than the current stock price, while the lowest is $21.04 (+22.75%) and the highest is $44.13 (+157.47%).

Price Target: $31.63 (+84.54%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$21.04$31.63$30.69$44.13
Change+22.75%+84.54%+79.05%+157.47%

Analyst Ratings

The average analyst rating for HKG:1877 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy444433
Buy000000
Hold111111
Sell000000
Strong Sell000000
Total555544

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
UBS
No rating
UBS
Buy
Maintains
$32.10$29.10
BuyMaintains$32.10$29.10+69.78%Sep 3, 2026
Unknown Analyst
SDIC Securities
No rating
SDIC Securities
Buy
Maintains
$26.84
BuyMaintains$26.84+56.59%Aug 29, 2026
Unknown Analyst
J.P. Morgan
No rating
J.P. Morgan
Hold
Maintains
$21.00
HoldMaintains$21.00+22.52%Aug 6, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$31.60
BuyMaintains$31.60+84.36%Apr 29, 2026
Unknown Analyst
Citi
No rating
Citi
Buy
Maintains
$32.00
BuyMaintains$32.00+86.70%Mar 16, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.43B
from 2.50B
Increased by 37.22%
Revenue Next Year
4.17B
from 3.43B
Increased by 21.71%
EPS This Year
-0.15
from -0.42
EPS Next Year
0.17
from -0.15
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
4.02B1.45B1.50B1.95B2.50B3.43B
Revenue Growth
152.36%-63.89%3.38%29.67%28.24%37.22%
Gross Profit
2.77B927.21M868.16M1.42B1.97B2.78B
Gross Margin
68.74%63.79%57.78%73.13%78.75%80.95%
Operating Income
-686.06M-2.76B-2.48B-1.35B-913.60M-328.51M
Net Income
-720.91M-2.39B-2.28B-1.28B-875.17M-123.35M
EPS
-----0.42-0.15
Free Cash Flow
-1.17B-1.31B-2.12B-1.10B-966.68M-74.00M
No. Analysts
-----4
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High3.5B
Avg3.4B
Low3.3B

Revenue Growth

Revenue Growth202620272028
High
41.8%
Avg
37.2%
Low
32.8%

EPS Forecast

EPS202620272028
High-0.15
Avg-0.15
Low-0.15

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-